Remdesivir Demonstrates Further Promise

June 18, 2020

Remdesivir Demonstrates Further Promise

Gilead Science’s antiviral COVID treatment, remdesivir, effectively prevents lung damage in macaque monkeys infected with coronavirus, according to findings published in Nature. Yourway offers direct-to-patient services to help trials continue to run and provide convenience for patients when they can’t leave their homes.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat

Hello! How can I help you?